{
    "nct_id": "NCT04422132",
    "official_title": "Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks",
    "inclusion_criteria": "* Men aged 18 and older with histologically confirmed prostate cancer after prostatectomy with detectable PSA. PSA does not need to be detectable for men with pathologically node positive disease.\n* KPS >=70\n* Patient with no evidence of distant metastatic disease on PET/CT/MRI or bone scan < 9 months prior to enrollment. Patients with positive pelvic lymph nodes are eligible.\n* Ability to receive MRI-guided radiotherapy.\n* Equivocal evidence of metastatic disease outside the pelvis on standard imaging requires documented negative biopsy.\n* Ability to complete the Expanded Prostate Cancer Index Composite (EPIC) questionnaire.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Prior history of receiving pelvic radiotherapy.\n* Patient with inflammatory bowel disease.\n* Patients with a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of ultra-hypofractionated radiotherapy.\n* History of bladder neck or urethral stricture.",
    "miscellaneous_criteria": ""
}